A detailed history of Great West Life Assurance CO transactions in Arvinas, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 14,524 shares of ARVN stock, worth $394,181. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,524
Previous 17,726 18.06%
Holding current value
$394,181
Previous $732,000 47.27%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$24.46 - $40.4 $78,320 - $129,360
-3,202 Reduced 18.06%
14,524 $386,000
Q1 2024

May 13, 2024

SELL
$36.38 - $52.31 $97,898 - $140,766
-2,691 Reduced 13.18%
17,726 $732,000
Q4 2023

Feb 13, 2024

BUY
$14.19 - $42.33 $56,774 - $169,362
4,001 Added 24.37%
20,417 $835,000
Q3 2023

Nov 14, 2023

BUY
$19.64 - $28.21 $54,677 - $78,536
2,784 Added 20.42%
16,416 $322,000
Q2 2023

Aug 10, 2023

BUY
$21.73 - $31.43 $31,508 - $45,573
1,450 Added 11.9%
13,632 $340,000
Q1 2023

May 12, 2023

SELL
$26.15 - $37.26 $631,313 - $899,530
-24,142 Reduced 66.46%
12,182 $333,000
Q4 2022

Feb 10, 2023

BUY
$32.47 - $57.24 $130,821 - $230,619
4,029 Added 12.48%
36,324 $1.25 Million
Q3 2022

Nov 01, 2022

BUY
$41.87 - $57.99 $1.35 Million - $1.87 Million
32,295 New
32,295 $1.44 Million
Q2 2022

Aug 09, 2022

BUY
$36.01 - $74.24 $656,462 - $1.35 Million
18,230 Added 102.5%
36,016 $1.51 Million
Q1 2022

May 12, 2022

BUY
$60.27 - $81.57 $944,913 - $1.28 Million
15,678 Added 743.74%
17,786 $1.27 Million
Q2 2021

Aug 11, 2021

BUY
$60.45 - $84.26 $967 - $1,348
16 Added 0.76%
2,108 $162,000
Q1 2021

May 17, 2021

BUY
$58.19 - $91.37 $48,646 - $76,385
836 Added 66.56%
2,092 $137,000
Q3 2020

Nov 17, 2020

SELL
$22.99 - $36.34 $591,670 - $935,246
-25,736 Reduced 95.35%
1,256 $29,000
Q3 2020

Nov 13, 2020

BUY
$22.99 - $36.34 $591,670 - $935,246
25,736 Added 2049.04%
26,992 $637,000
Q2 2020

Aug 17, 2020

BUY
$29.88 - $56.74 $21,244 - $40,342
711 Added 130.46%
1,256 $42,000
Q4 2019

Feb 11, 2020

BUY
$15.39 - $44.38 $8,387 - $24,187
545 New
545 $22,000
Q3 2019

Oct 25, 2019

SELL
$21.55 - $27.61 $22,153 - $28,383
-1,028 Closed
0 $0
Q2 2019

Jul 31, 2019

BUY
$15.96 - $23.8 $16,406 - $24,466
1,028 New
1,028 $0

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.44B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.